A5031796482- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Organ Transplantation Techniques and Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis B Virus Studies
- Renal Transplantation Outcomes and Treatments
- Hepatitis Viruses Studies and Epidemiology
- Autoimmune Bullous Skin Diseases
- Autoimmune and Inflammatory Disorders
- Metabolism and Genetic Disorders
- Pharmacological Effects and Toxicity Studies
- Congenital Diaphragmatic Hernia Studies
- Medical Imaging and Pathology Studies
- Antibiotic Resistance in Bacteria
- Clostridium difficile and Clostridium perfringens research
- Pleural and Pulmonary Diseases
- Gastrointestinal disorders and treatments
- Trace Elements in Health
- Genetic and rare skin diseases.
University Health Network
2024-2025
Universitat Autònoma de Barcelona
2022-2025
Toronto General Hospital
2025
University of Toronto
2024
Vall d'Hebron Hospital Universitari
2021-2024
Vall d'Hebron Institut de Recerca
2022-2024
Hospital General Universitario Gregorio Marañón
2022
614 Background: Liver transplantation (LT) offers a 5-year survival exceeding 70% for selected patients with hepatocellular carcinoma (HCC). Immune checkpoint inhibitors (ICIs) may be used to downstage or bridge transplantation. This study aims evaluate the safety of ICIs prior LT. Methods: Multicenter retrospective study, involving 9 centers, included adults who received and, subsequent LT, between 2019 and 2023. The ICI cohort was matched by age, sex, liver diseases transplant date (1:3)...
Hepatocellular carcinoma (HCC) recurs after liver transplantation (LT) in ~17% of patients. We aimed to retrospectively compare the outcomes patients treated with different tyrosine kinase inhibitors (TKIs) for recurrent HCC post-LT.
Background and Aims Immunotherapy with immune checkpoint inhibitors (ICIs) is a pillar of many advanced tumors. However, there scarce data concerning the rate viral hepatitis screening in this population or risk reactivation. Methods Retrospective–prospective study that includes all patients who began ICIs between January/2019 December/2020 University Hospital. Data on prior to beginning were collected. In subjects lacking information, serological tests requested prospectively. Among HBsAg,...
Zinc homeostasis could play a role in compensated advanced chronic liver disease, and its supplementation has been linked to improvement function, decrease of hepatic complications, reduction HCC incidence. Compensated disease encompasses heterogeneous group patients with variable risks clinically significant portal hypertension clinical events. The ANTICIPATE model is validated for stratifying these risks. Our aim demonstrate that zinc administration can reduce the rate risk presenting...
Radiofrequency ablation is one of the most commonly used therapies for potentially curative small hepatocellular carcinoma. Although radiofrequency usually a safe procedure, severe and fatal complications can happen. This case 72 years old woman with cirrhosis secondary to Metabolic Associated Fatty Liver Disease (MAFLD), who presented recurrent hydrothorax after treating carcinoma (HCC) (RFA), in which diaphragmatic perforation was subsequently diagnosed. We reviewed differential diagnosis...